ACADIAN ASSET MANAGEMENT LLC - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$272,000
-44.5%
1,373,376
+26.5%
0.00%
-50.0%
Q3 2018$490,000
-16.0%
1,086,095
-6.2%
0.00%
-33.3%
Q2 2018$583,000
+3.6%
1,157,880
+378.4%
0.00%
+50.0%
Q1 2018$563,000–242,017–0.00%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2023
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders